![Keith R. Walley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Keith R. Walley
Corporate Officer/Principal bei University of British Columbia
Aktive Positionen von Keith R. Walley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of British Columbia | Corporate Officer/Principal | - | - |
Karriereverlauf von Keith R. Walley
Ehemalige bekannte Positionen von Keith R. Walley
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cyon Therapeutics, Inc.
![]() Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Gründer | 01.05.2014 | 02.05.2014 |
Sirius Genomics, Inc.
![]() Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | 01.01.2001 | - |
Gründer | 01.01.2001 | - |
Ausbildung von Keith R. Walley
University of Manitoba | Doctorate Degree |
Statistik
International
Kanada | 5 |
Operativ
Founder | 2 |
Director/Board Member | 1 |
Doctorate Degree | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Sirius Genomics, Inc.
![]() Sirius Genomics, Inc. Pharmaceuticals: MajorHealth Technology Sirius Genomics, Inc. develops DNA-based diagnostic and pharmacogenetic products. Its product is Sepsis. It also develops companion diagnostics, that are closely tied to therapeutic decisions, leading to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable CDx products. Sirius Genomics was founded by James A. Russell and Keith Walley in 2001 and is headquartered in Vancouver, Canada. | Health Technology |
Cyon Therapeutics, Inc.
![]() Cyon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyon Therapuetics, Inc. operates as a clinical phase biotechnology company. It provides anti-PCSK9 which develops the treatment for sepsis-severe. The company was founded by James Russell, Keith Walley and John Boyd in May 2014 and is headquartered in Vancouver, Canada. | Commercial Services |
- Börse
- Insiders
- Keith R. Walley
- Erfahrung